Outpatient 60‐hour day‐and‐night glucose control with dual‐hormone artificial pancreas, single‐hormone artificial pancreas, or sensor‐augmented pump therapy in adults with type 1 diabetes: An open‐label, randomised, crossover, controlled trial
Ahmad Haidar; Virginie Messier; Laurent Legault; Martin Ladouceur; Rémi Rabasa‐Lhoret
Author Information: Faculty of Medicine, Department of Biomedical Engineering
Checking for direct PDF access through Ovid |
Abstract
Abstract unavailable for this article.